nishithadmin
-
17 September 2024 at 11 : 16 AM
Deal Corner: NDA Represents GIC For Its Funding of INR 1,674 Crore (~USD 200 Million) In Data Infrastructure Trust for The Acquisition of American Tower Corporation, India
Read MoreSepetember 17, 2024 NDA Represents GIC For Its Funding of INR 1,674 Crore (~USD 200 Million) In Data Infrastructure Trust for The Acquisition of American Tower Corporation, India DEAL BRIEF GIC, through its affiliate Anahera Investments Pte Limited, funded Data InvIT with INR 1,674 crore (~USD 200 Million) to fund the acquisition of American […]
-
15 September 2024 at 14 : 25 PM
Article: Acquirers Beware: Indian Merger Control Regime Revamped!
Read MoreSeptember 15, 2024 Acquirers Beware: Indian Merger Control Regime Revamped! 1. BACKGROUND The Competition Act, 2002 (“Competition Act”) was amended on April 11, 2023 vide the Competition (Amendment) Act, 2023 (the “Competition Amendment Act”). The Competition Amendment Act had introduced certain changes to the merger control regime, provisions on behavioural issues as well as the enforcement framework […]
-
13 September 2024 at 10 : 32 AM
M&A Lab: Lights, Camera, No Action: Collapse of the Zee-Sony Merger
Read MoreSeptember 13, 2024 Lights, Camera, No Action: Collapse of the Zee-Sony Merger The merger between Zee Entertainment Enterprises Limited (ZEEL) and Sony Pictures Networks India (SPNI) was intended to create a media giant by combining their networks, digital platforms, and content libraries. The new entity, with Sony holding a majority stake, was expected […]
-
12 September 2024 at 17 : 30 PM
FEMA Hotline: Inbound Investment Rules Liberalized – Cross-Border Share Swaps Simplified!!
Read MoreSeptember 12, 2024 Inbound Investment Rules Liberalized – Cross-Border Share Swaps Simplified!! Amended Rules have simplified the cross-border share swaps for greater ease of doing business Encouraging FDI in White Label ATM operations to extend banking services to the underserved areas Standardizing and harmonizing ‘control’ and ‘start-up’ with the other laws or notifications On […]
-
11 September 2024 at 13 : 40 PM
Deal Corner: NDA Represents Nuveen in Its Investment in Epimoney Private Limited
Read MoreSepetember 11, 2024 NDA Represents Nuveen in Its Investment in Epimoney Private Limited DEAL BRIEF NCIF II Lux S.á.r.l. (“Nuveen”) has signed definitive documents to participate in the Series C Funding Round of Epimoney Private Limited, a non-banking financial company classified as an NBFC-ICC and commonly known as “Flexiloans”, along with other institutional […]
-
7 September 2024 at 09 : 04 AM
Pharma & Healthcare Update: New Promotion Code Released: Medical Device Industry to Breathe Easy
Read MoreSeptember 07, 2024 New Promotion Code Released: Medical Device Industry to Breathe Easy The DoP has released a separate marketing code which accounts for the distinct nature of the activities undertaken by medical devices companies Companies are required to adhere to certain transparency requirements The enforcement of UCMPMD will be through industry associations BACKGROUND […]
-
3 September 2024 at 13 : 24 PM
New Publication: Telemedicine in India
Read MoreThe Future of Medical Practice September 03, 2024 In the Indian context, telemedicine has the potential to increase access to quality healthcare for all Indians and the practice continues to grow rapidly through the years. In this paper, we have discussed various telemedicine business models, the legal and regulatory framework regulating telemedicine and […]
-
2 September 2024 at 15 : 37 PM
New Publication: Clinical Trials and Biomedical Research in India
Read MoreLegal and Regulatory Framework September 02, 2024 Clinical trials in India has been a buzzing topic in the pharmaceutical industry for decades. In the past few years, the industry has witnessed a growing interest from foreign players seeking to conduct clinical trials in India to cater to global demands. The industry is striding […]
-
2 September 2024 at 10 : 24 AM
Deal Talk: Deal Making Insights – Lessons from Proxy Advisory Firms
Read MoreSeptember 02, 2024 Deal Making Insights – Lessons from Proxy Advisory Firms Introduction: Companies, undertaking business operations in India, are obliged to comply with the Companies Act, 2013 (‘CA 2013’), which requires them to undertake operations and make decisions through two means- (a) board decisions and (b) shareholder decisions. Matters like inspection of books […]
-
30 August 2024 at 12 : 36 PM
Green Hotline: India Budget 2024: Fueling Green Growth
Read MoreAugust 30, 2024 India Budget 2024: Fueling Green Growth The India 2024 Budget significantly boosts funding and has introduced policies for renewable energy initiatives, with a strong focus on green hydrogen, solar and thermal energy, and nuclear power, demonstrating India’s commitment to sustainable growth. Framework related initiatives have also been introduced via the India […]
-
29 August 2024 at 12 : 03 PM
Deal Corner: NDA Represents Medi Assist in their proposed 100% acquisition of Paramount TPA from Fairfax and Dr. Nayan Shah & Family
Read MoreAugust 29, 2024 NDA Represents Medi Assist in their proposed 100% acquisition of Paramount TPA from Fairfax and Dr. Nayan Shah & Family DEAL BRIEF Medi Assist Insurance TPA Private Limited has signed definitive agreements for proposed 100% acquisition of Paramount Health Services & Insurance TPA Pvt. Limited, a prominent player in the TPA […]
-
26 August 2024 at 12 : 13 PM
Deal Talk: Legacy Reimagined: Godrej Family Restructuring
Read MoreAugust 26, 2024 Legacy Reimagined: Godrej Family Restructuring Introduction Godrej, a pioneering conglomerate which came into existence during the Swadeshi Movement in 1897, is a household name in India, well known across industries ranging from real estate to consumer goods. The Godrej group has businesses ranging from real estate to consumer goods, each […]
-
23 August 2024 at 13 : 25 PM
Article: Navigating the Boom: Rise of M&A in Healthcare
Read MoreAugust 23, 2024 Navigating the Boom: Rise of M&A in Healthcare Despite a subdued growth trajectory in Mergers and Acquisitions (M&A) and Private Equity (PE) activities throughout 2023 and the early months of 2024, the Indian healthcare and pharmaceutical sectors experienced a significant surge in deal activity during the first two quarters of this […]
-
22 August 2024 at 16 : 40 PM
Yes, Governance Matters.: Are current Class Action Suit provisions in India sufficient for ESG related disputes?
Read MoreAugust 22, 2024 Are current Class Action Suit provisions in India sufficient for ESG related disputes? Class Actions Suits introduced as a remedy for shareholders, but remains underutilized in India, especially in ESG-related disputes The Indian CAS system draws inspiration from the U.S. but has stricter requirements, making it challenging to initiate and sustain […]
-
22 August 2024 at 11 : 06 AM
Article: Navigating The Change in Shareholding and Management Rule for Non-Banking Financial Companies in India: A Practical Perspective
Read MoreAugust 22, 2024 Navigating The Change in Shareholding and Management Rule for Non-Banking Financial Companies in India: A Practical Perspective Under the existing Scale Based Regulations, 2023 applicable to non-banking financial companies in India, changes in shareholding of 26% of more and changes to the management of 30% or more are currently subject to […]
-
21 August 2024 at 12 : 58 PM
New Publication: Digital Health in India
Read MoreAugust 21, 2024 Digital Health technology has emerged as a pivotal pillar in the delivery of healthcare. There has been tremendous research and development in the integration of technologies such as robotics, artificial intelligence, blockchain and virtual reality with pharmaceuticals and healthcare. In the absence of a specific Digital Health law, this paper seeks […]
